Inclinix
Wilmington
About Inclinix
Inclinix, Inc. is a division of Inclinix-PMG Holdings, Inc., the industry's most innovative solution for clinical trial enrollment that combines the world-class sites of PMG Research Inc. with Inclinix's premier patient recruitment solutions. Inclinix specializes in customized Phase I-IV clinical enrollment solutions for global pharmaceutical, biotechnology, and medical device organizations. Clients benefit from twelve years of experience in multiple therapeutic areas, as well as leading edge technologies that meet the challenge of clinical development from feasibility through compliance. Inclinix delivers a customized, site-focused approach to patient recruitment ensuring every available study candidate is identified, qualified and presented with a study opportunity. By combining our powerful in-field approach with social media and highly targeted advertising, Inclinix creates effective outreach campaigns breitling replica watches that result in enrolled patients and productive sites.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $30.6M
- Last round: Series Unknown (Jun 2014)
- Website: inclinix.com
- Phone: 910-395-5674
Industries & Categories
Biotechnology, Medical Device, Pharmaceutical
Canonical: https://fsome.com/organization/inclinix-3613998 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.